Literature DB >> 2868632

Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi.

A M Ruiz, M Esteva, P Cabeza Meckert, R P Laguens, E L Segura.   

Abstract

Mice were immunized with subcellular fractions obtained by differential centrifugation from epimastigotes of Trypanosoma cruzi (Tulahuén strain). In a chronic model of Chagas' disease, they were challenged each with 25 bloodstream trypomastigotes. Non-immunized, non-challenged and non-immunized challenged animals were kept as controls. Among the challenged mice, those immunized with 105,000 g pellet (Mc) and 105,000 g supernatant (Cs) fractions presented positive xenodiagnosis, myocarditis and myositis similar to those shown by non-immunized challenged controls. The fractions enriched in flagella, the 5000 g pellet (P5) and the flagellar fraction (F) resulted in fewer animals with positive xenodiagnosis and in hosts partially protected from the development of myocarditis. In the absence of infection, Mc and Cs induced an intense myocarditis while F induced mild lesions similar to those found in the controls. P5 caused a myocarditis intermediate between that elicited by Mc and that in the controls. 50% of the animals immunized with Cs presented pathological electrocardiograms in the absence of challenge. The animals immunized with F and P5 and challenged were protected against the development of pathological electrocardiograms, whereas those immunized with Mc and Cs behaved like the non-immunized controls. The immunized, non-challenged animals presented anti-T. cruzi IgG antibodies, with titres which were lower than those shown by the immunized and challenged mice.--The results show the possibility of obtaining tissue lesions with antigenic preparations of T. cruzi in the absence of infection, and suggest that the mechanisms involved in the generation of myocarditis and electrocardiographic alterations are probably different, since these pathologies can be elicited by different subcellular fractions. Among the antigenic components of the parasite, the flagellar fraction gave the best immunoprotective properties, with little or no immunoaggressive effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2868632

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  11 in total

1.  Expression in Escherichia coli of a dominant immunogen of Trypanosoma cruzi recognized by human chagasic sera.

Authors:  P C Cotrim; G S Paranhos; R A Mortara; J Wanderley; A Rassi; M E Camargo; J F da Silveira
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Presence of anti-Trypanosoma cruzi antibodies in the sera of mice with experimental autoimmune myocarditis.

Authors:  J G Chambó; P M Cabeza Meckert; R P Laguens
Journal:  Experientia       Date:  1990-09-15

3.  Major Trypanosoma cruzi antigenic determinant in Chagas' heart disease shares homology with the systemic lupus erythematosus ribosomal P protein epitope.

Authors:  E A Mesri; G Levitus; M Hontebeyrie-Joskowicz; G Dighiero; M H Van Regenmortel; M J Levin
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection.

Authors:  R A Wrightsman; M J Miller; J L Saborio; J E Manning
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Antiheart antibody-dependent cytotoxicity in the sera of mice chronically infected with Trypanosoma cruzi.

Authors:  R P Laguens; P C Meckert; J G Chambó
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

6.  Differences in resistance to reinfection with low and high inocula of Trypanosoma cruzi in chagasic mice treated with nifurtimox and relation to immune response.

Authors:  P Cabeza Meckert; J G Chambó; R P Laguens
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

7.  The repetitive cytoskeletal protein H49 of Trypanosoma cruzi is a calpain-like protein located at the flagellum attachment zone.

Authors:  Alexandra Galetović; Renata T Souza; Marcia R M Santos; Esteban M Cordero; Izabela M D Bastos; Jaime M Santana; Jeronimo C Ruiz; Fabio M Lima; Marjorie M Marini; Renato A Mortara; José Franco da Silveira
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

Review 8.  Experimental Vaccines against Chagas Disease: A Journey through History.

Authors:  Olivia Rodríguez-Morales; Víctor Monteón-Padilla; Silvia C Carrillo-Sánchez; Martha Rios-Castro; Mariana Martínez-Cruz; Alejandro Carabarin-Lima; Minerva Arce-Fonseca
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

9.  Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection.

Authors:  Gurdip Singh Mann; Amanda F Francisco; Shiromani Jayawardhana; Martin C Taylor; Michael D Lewis; Francisco Olmo; Elisangela Oliveira de Freitas; Fabiana M S Leoratti; Cesar López-Camacho; Arturo Reyes-Sandoval; John M Kelly
Journal:  PLoS Negl Trop Dis       Date:  2020-04-17

Review 10.  Epidemiology of Trypanosomiasis in Wildlife-Implications for Humans at the Wildlife Interface in Africa.

Authors:  Keneth Iceland Kasozi; Gerald Zirintunda; Fred Ssempijja; Bridget Buyinza; Khalid J Alzahrani; Kevin Matama; Helen N Nakimbugwe; Luay Alkazmi; David Onanyang; Paul Bogere; Juma John Ochieng; Saher Islam; Wycliff Matovu; David Paul Nalumenya; Gaber El-Saber Batiha; Lawrence Obado Osuwat; Mahmoud Abdelhamid; Tianren Shen; Leonard Omadang; Susan Christina Welburn
Journal:  Front Vet Sci       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.